Li Shoufeng, Lin Senshang, Daggy Bruce P, Mirchandani Haresh L, Chien Yie W
Controlled Drug-Delivery Research Center, College of Pharmacy, Rutgers, State University of New Jersey, Piscataway, New Jersey 08854, USA.
Drug Dev Ind Pharm. 2002 Aug;28(7):783-93. doi: 10.1081/ddc-120005624.
To evaluate the contribution of formulation variables on the floating properties of a gastric floating drug delivery system (GFDDS) using a continuous floating monitoring system and statistical experimental design.
A modified continuous floating monitoring system, which consisted of an electric balance interfacing with a PC, was designed to perform the continuous monitoring of floating kinetics of GFDDS. Several formulation variables, such as different types of hydroxypropyl methylcellulose (HPMC), varying HPMC/Carbopol ratio, and addition of magnesium stearate, were evaluated using Taguchi design, and the effects of these variables were subjected to statistical analysis.
The continuous floating monitoring system developed was validated, using capsules with different density, and a good correlation between theoretical and experimental values was obtained (R2 = 0.9998), indicating the validity of the setup. The statistical analysis indicated that magnesium stearate had a significant effect on the floating property of GFDDS (p < 0.05), and addition of magnesium stearate could significantly improve the floating capacity of the GFDDS. It was found that the HPMC of higher viscosity grade generally exhibited a greater floating capacity, but the effect was not statistically significant. For polymers with the same viscosity, i.e., K4M and E4M, the degree of substitution of the function group did not show any significant contribution. A better floating behavior was achieved at higher HPMC/Carbopol ratio. Carbopol appeared to have a negative effect on the floating behavior of GFDDS.
It was concluded that by using a validated continuous floating monitoring system, the effect of formulation variables on the floating property of the delivery system and their ranges could be identified. Incorporation of hydrophobic agents, such as magnesium stearate, could significantly improve the floating capacity of the GFDDS.
使用连续漂浮监测系统和统计实验设计,评估制剂变量对胃漂浮药物递送系统(GFDDS)漂浮特性的影响。
设计了一种改进的连续漂浮监测系统,该系统由与个人计算机连接的电子天平组成,用于对GFDDS的漂浮动力学进行连续监测。使用田口设计评估了几个制剂变量,如不同类型的羟丙基甲基纤维素(HPMC)、不同的HPMC/卡波姆比例以及硬脂酸镁的添加,并对这些变量的影响进行了统计分析。
使用不同密度的胶囊对所开发的连续漂浮监测系统进行了验证,理论值与实验值之间具有良好的相关性(R2 = 0.9998),表明该装置的有效性。统计分析表明,硬脂酸镁对GFDDS的漂浮特性有显著影响(p < 0.05),添加硬脂酸镁可显著提高GFDDS的漂浮能力。发现较高粘度等级的HPMC通常表现出更大的漂浮能力,但该影响在统计学上不显著。对于具有相同粘度的聚合物,即K4M和E4M,官能团的取代度没有显示出任何显著贡献。在较高的HPMC/卡波姆比例下可实现更好的漂浮行为。卡波姆似乎对GFDDS的漂浮行为有负面影响。
得出结论,通过使用经过验证的连续漂浮监测系统,可以确定制剂变量对递送系统漂浮特性的影响及其范围。加入疏水剂,如硬脂酸镁,可显著提高GFDDS的漂浮能力。